Study Evaluates Hypoxia Risks During Bedside Eye Injections for Premature Infants
A multicenter study of 74 premature infants undergoing bedside ranibizumab injections found a 16.2 percent incidence of transient, non-severe hypoxia, ...
A multicenter study of 74 premature infants undergoing bedside ranibizumab injections found a 16.2 percent incidence of transient, non-severe hypoxia, ...
A three-year analysis using decision tree and Markov modeling found that intravitreal ranibizumab is highly cost-effective compared with laser photocoagulation ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.